Is the improved version of gene editing technology actually a "magic weapon" for controlling obesity and diabetes? NeuroBo to be listed on Nasdaq via reverse merger with Gemphire Irrational feedback: ...
FORMA's mIDH1 inhibitor Olutasidenib Overview Where does the money for public health go? The first round of 2020 pharmaceutical procurement: Guangdong's procurement model may adjust price linkage!